¹ú²úÂ鶹¾«Æ·

  1. Home
  2. Coronavirus Disease (COVID-19)

Coronavirus Disease (COVID-19)

Coronaviruses (CoV) are a large family of viruses that cause illness ranging from the common cold to more severe diseases. The COVID-19 epidemic was declared by the WHO as a public health emergency of international concern on January 30, 2020. The Director-General of the World Health Organization (WHO), Dr. Tedros Adhanom Ghebreyesus, announced on 11 March 2020 that the new coronavirus disease 2019 (COVID-19) can be characterized as a pandemic. Describing the situation as a pandemic means that the epidemic has spread to several countries, continents or throughout the world, and that it affects large numbers of people.

Visit the COVID-19 Pandemic Page.   ABOUT CORONAVIRUS INFECTIONS

 Documents and Articles

Fecha
COVID-19 variants
Update on variant of interest EG.5 and variant under surveillance BA.2.86
¹ú²úÂ鶹¾«Æ· Monthly COVID-19 Epidemiological Update - August 2023
¹ú²úÂ鶹¾«Æ· Response to COVID-19 2022. Summary Report on US Government Funding Allocated under the American Rescue Plan Act.
Jarbas Barbosa, Director of ¹ú²úÂ鶹¾«Æ· (¹ú²úÂ鶹¾«Æ·)
¹ú²úÂ鶹¾«Æ· Director statement on External Evaluation Report of Organization’s Response to COVID-19
Servicios de salud Honduras
Healthcare service disruptions during COVID-19 in Latin America and the Caribbean
COVID-19 virus
COVID-19 no longer constitutes a public health emergency of international concern
Older adult receives vaccine.
SAGE updates COVID-19 vaccination guidance
woman checks boxes in a warehouse
USG and the ¹ú²úÂ鶹¾«Æ· Revolving Fund provide relief to countries in need of vaccines and strengthen the region supply chain
Nurse Samanta Toney working in the COVID-19 Intensive Care Unit in 's Lands Hospital in Suriname.
Leading a Team of Nurses in the COVID-19 ICU During the Pandemic
Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19
Evaluation of COVID-19 vaccine effectiveness in a changing landscape of COVID-19 epidemiology and vaccination: interim guidance, 1 October 2022: second addendum to Evaluation of COVID-19 vaccine effectiveness: interim guidance
¹ú²úÂ鶹¾«Æ· ITU collaboration
¹ú²úÂ鶹¾«Æ· ITU Communications ECC campaign a success!
Pan American Health Organization Response to COVID-19. 2022 mid-year summary report. Key indicators and selected highlights
COVID-19 pandemic in the Americas. Response Strategy and Donor Appeal April 2022 – March 2023. Summary
Luiz Lima, Deputy Director of Production at Bio-Manguinhos-Fiocruz, working with a colleague.
For vaccine equity: producers work together to advance mRNA technology in Latin America
Third round of the National Survey on the Continuity of Essential Health Services during the COVID-19 Pandemic: November-December 2021. Interim report for the Region of the Americas, January 2022
Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine